GlassScriptPhysician profile
Brent R Mcqueen
NPI 1043216534
$1,853.31
in general payments reported to CMS, 2019-2025
16 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2021: $90.00 · 2022: $282 · 2023: $357 · 2024: $395 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $793.15 | 2022-2025 | |
| Glaukos Corporation | $298.47 | 2023-2025 | Idosetr, Idose |
| Alcon Vision LLC | $172.91 | 2019-2024 | Clareon, Rocklatan, Simbrinza |
| Bausch & Lomb Americas INC. | $128.82 | 2022-2025 | Miebo, Vyzulta, Toric |
| Omeros Corporation | $78.81 | 2019 | |
| Carl Zeiss Meditec, INC. | $72.40 | 2019 | |
| Allergan, INC. | $46.85 | 2021 | |
| Eyevance Pharmaceuticals LLC | $46.62 | 2022-2023 | Flarex |
| Tarsus Pharmaceuticals, INC. | $43.75 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $33.60 | 2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $30.27 | 2025 | |
| New World Medical,INC. | $26.23 | 2025 | Ahmed Glaucoma Valve, Streamline, Via360 |
| Staar Surgical Company | $23.05 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.47 | 2019 | |
| Rxsight INC | $19.58 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $17.33 | 2024 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Mcqueen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.